LYVISPAH (baclofen oral granules) Patient Assistance Program
Don’t let the high cost of brand baclofen granules disrupt your spasticity care. We help eligible patients access Lyvispah (baclofen oral granules) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Lyvispah (baclofen oral granules) is FDA-approved for the treatment of reversible spasticity associated with multiple sclerosis and spinal cord injuries. Same active ingredient as generic oral baclofen but in a granule formulation designed for patients with swallowing difficulties or those who need flexible dosing.
- Without assistance, brand Lyvispah costs commonly run approximately $700–$1,000 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Lyvispah for a flat $69.95 per month.
- Generic oral baclofen tablets (5 mg, 10 mg, 20 mg) widely available very cheap (~$10–$25/month). Other antispasticity agents: tizanidine (Zanaflex generic), dantrolene (Dantrium generic), diazepam (generic), cyclobenzaprine (Flexeril generic). For severe spasticity: intrathecal baclofen pump (Lioresal Intrathecal, generic baclofen for refillable pumps), onabotulinumtoxinA (Botox) injections for focal spasticity, phenol or alcohol nerve blocks. For MS-specific spasticity: dalfampridine (Ampyra — generic now). For spinal cord injury: physical therapy, stretching, splinting, surgical interventions (selective dorsal rhizotomy for some pediatric patients). Cannabis-based products (nabiximols — outside US) for MS spasticity in some countries. Lyvispah is appropriate for patients who cannot swallow tablets or who benefit from the precise dose flexibility of granules.
What is Lyvispah Prescription Assistance Program?
The Lyvispah Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Lyvispah (used for treatment of reversible spasticity from multiple sclerosis and spinal cord injuries) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, neurology or rehabilitation medicine coordination, supporting documentation, and ongoing renewal — which can be overwhelming when you are managing chronic neurologic disease.
At AffordMyPrescriptions, our Patient Advocates handle the entire Lyvispah PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your prescriber for required medical documentation, follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Lyvispah antispasticity therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Lyvispah enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your multiple sclerosis or spinal cord injury treatment.
Pharmacy Price Comparison
- Without assistance, Lyvispah costs hundreds of dollars per month at retail pharmacies. Discount cards and pharmacy coupons offer some relief, but they don't come close to what a Patient Assistance Program provides if you qualify. The table below compares typical retail pricing across major pharmacies to what you'd pay with our Lyvispah advocacy service:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$960/mo | Save substantially |
| CVS Pharmacy (brand) | ~$1,000/mo | Save substantially |
| Walmart (brand) | ~$760/mo | Save substantially |
| Costco (brand) | ~$720/mo | Save substantially |
| Generic oral baclofen tablets | ~$15/mo | Generic — very cheap |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Lyvispah — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Lyvispah Prescription Program?
The Lyvispah Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork. Generic oral baclofen tablets are very inexpensive and provide essentially the same effect; Lyvispah granules are appropriate for patients with swallowing difficulties.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Lyvispah:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Cards expire and require constant renewal
Still $700–$1,000 per month even with the best discount
- Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and renewals
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Lyvispah assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Lyvispah Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Lyvispah:
Lyvispah is baclofen in a granule formulation packaged in single-dose stick packs (5 mg, 10 mg, and 20 mg). The granule form is designed for patients who cannot swallow tablets, who require feeding tube administration, or who need fine dose flexibility (combining stick packs for intermediate doses). Same active drug as generic oral baclofen tablets.
How Lyvispah Works:
Spasticity in multiple sclerosis and spinal cord injury results from disrupted descending inhibitory pathways — leading to increased reflex activity, muscle tone, and painful spasms that interfere with mobility, hygiene, and quality of life.
Baclofen is a GABA-B receptor agonist that inhibits both monosynaptic and polysynaptic reflexes at the spinal cord level — reducing muscle tone and spasm severity. Lyvispah’s granule formulation delivers the same active drug as oral tablets, with the advantage of easier administration in patients with dysphagia or who use feeding tubes, and finer dose granularity from combining stick packs.
Form and Use:
Lyvispah granules in single-dose stick packs (5 mg, 10 mg, 20 mg). Sprinkle contents onto soft food (applesauce, pudding) or mix with liquid and swallow. Initial dose 5 mg three times daily; titrate upward by 5 mg increments every 3 days as tolerated. Typical maintenance 40–80 mg/day in divided doses; max 80 mg/day in 3–4 divided doses. **Do not abruptly discontinue — withdrawal can cause hallucinations, seizures, hyperthermia, rebound spasticity (potentially severe — gradual taper essential).** Take with or without food. Renal dose adjustment.
Generic Availability:
Generic oral baclofen tablets (5 mg, 10 mg, 20 mg) widely available — very cheap. For patients who cannot swallow tablets, generic oral baclofen can sometimes be crushed (consult pharmacist), or compounded into oral suspension by a compounding pharmacy. Other antispasticity agents: tizanidine (Zanaflex generic — alpha-2 agonist, more sedation, monitor liver function), dantrolene (Dantrium generic — peripheral mechanism, hepatotoxicity risk), diazepam (generic — also GABA modulation but with abuse potential), cyclobenzaprine (Flexeril generic — for muscle spasm, not spasticity per se). Intrathecal baclofen pump (Lioresal Intrathecal or generic baclofen for refills) for severe spasticity not adequately controlled by oral therapy. OnabotulinumtoxinA (Botox) for focal spasticity. Phenol or alcohol nerve blocks. For MS spasticity specifically: dalfampridine (Ampyra — generic now, improves walking) does not directly treat spasticity but improves mobility. Cannabinoid-based products (nabiximols — outside US) for MS spasticity. Physical therapy, stretching, splinting, range-of-motion exercises, and surgical interventions (selective dorsal rhizotomy for some pediatric patients) are important non-pharmacologic components.
Warnings:
**Abrupt discontinuation can cause withdrawal syndrome — hallucinations, seizures, hyperthermia, rebound severe spasticity, mood changes — taper gradually over at least 1–2 weeks; intrathecal baclofen pump withdrawal can be life-threatening.** Sedation (very common), drowsiness, dizziness, weakness, fatigue, nausea, constipation, ataxia, hypotension, hypotonia, lowered seizure threshold (caution with seizure disorder), confusion and hallucinations (especially elderly). Renal dose adjustment for impaired kidney function. Use with caution with other CNS depressants (alcohol, opioids, benzodiazepines, sedating antihistamines). Pregnancy: limited data — weigh risks vs benefits. Lactation: limited data.
FAQ (Frequently Asked Questions)
How much does Lyvispah cost without insurance?
Brand Lyvispah $700–$1,000 per month. Generic oral baclofen tablets cost $10–$25 per month — substantial savings. Generic tizanidine (alternative antispasticity agent) costs $10–$25 per month.
What is the difference between Lyvispah and generic oral baclofen tablets?
Same active drug (baclofen) — same clinical effect on spasticity. Lyvispah is in granule formulation packaged in single-dose stick packs, designed for patients who cannot swallow tablets, who use feeding tubes, or who benefit from fine dose granularity. Generic tablets are dramatically cheaper but require swallowing whole or crushing/compounding for patients with dysphagia.
Why aren't generic oral baclofen tablets tried before Lyvispah?
They typically are — generic oral baclofen is the standard first-line antispasticity therapy for MS and spinal cord injury. Lyvispah granules are appropriate when patients cannot swallow tablets, when feeding tube administration is needed, or when finer dose flexibility is helpful.
Can Lyvispah be given through a feeding tube?
Yes — granules can be mixed with water or compatible liquid and given through nasogastric or gastrostomy tube. Flush with adequate water. This is a key advantage for patients with severe dysphagia.
What happens if I stop taking Lyvispah suddenly?
Abrupt discontinuation of baclofen can cause withdrawal syndrome — hallucinations, seizures, hyperthermia, rebound severe spasticity, mood changes. Always taper gradually over at least 1–2 weeks under medical supervision. Intrathecal baclofen pump withdrawal can be life-threatening — immediate medical attention required for pump malfunction.
What are the most common side effects of Lyvispah?
Sedation, drowsiness, dizziness, weakness, nausea, fatigue, constipation, ataxia, hypotonia, headache, confusion (especially elderly). Typically dose-related and may improve with continued use. Slow titration minimizes side effects.
What is the difference between oral baclofen and intrathecal baclofen pump therapy?
Oral baclofen reaches the spinal cord through systemic circulation — most of the dose is metabolized peripherally before reaching the cord. Intrathecal baclofen pump delivers small doses directly into the cerebrospinal fluid — providing dramatically more potent antispasticity effect with substantially fewer systemic side effects. Pump therapy is reserved for severe spasticity not adequately controlled by maximum oral therapy or limited by side effects.
What happens if my Lyvispah Patient Assistance Program application is denied?
We help explore generic oral baclofen tablets (substantial savings — can be crushed or compounded for swallowing difficulties), compounded baclofen oral suspension from a compounding pharmacy, generic tizanidine or dantrolene as alternative antispasticity agents, manufacturer copay programs, MS Society (National Multiple Sclerosis Society) patient support, spinal cord injury foundations, Patient Advocate Foundation, NeedyMeds, physical and occupational therapy programs, evaluation for intrathecal baclofen pump for severe refractory spasticity, and Botox injection for focal spasticity (often well-covered).
Take Control of Your Medication Costs
Spasticity management should not be skipped over cost. Generic oral baclofen tablets are very inexpensive and effective for most patients — Lyvispah granules are valuable for those with swallowing difficulties. Our Lyvispah advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Lyvispah through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.